Narrow search
Showing 1 - 10 of 23
Cover Image
The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention : the case of general colorecta...
Tscheulin, Dieter K.; Drevs, Florian - In: The European journal of health economics : HEPAC ; … 11 (2010) 2, pp. 141-150
Persistent link: https://www.econbiz.de/10003948354
Cover Image
On the welfare theoretic foundation of cost-effectiveness analysis : the case when survival is not affected
Liljas, Bengt - In: The European journal of health economics : HEPAC ; … 11 (2010) 1, pp. 5-13
Persistent link: https://www.econbiz.de/10003942635
Cover Image
Health costs in patients treated for depression, in patients with depressive symptoms treated for another chronic disorder, and in non-depressed patients : a two-year prospective c...
Hamre, Harald J.; Witt, Claudia M.; Glockmann, Anja; … - In: The European journal of health economics : HEPAC ; … 11 (2010) 1, pp. 77-94
Persistent link: https://www.econbiz.de/10003942711
Cover Image
Economic valuation and determinants of informal care to people with Alzheimer’s disease
Peña-Longobardo, Luz María; Oliva, Juan - In: The European journal of health economics : HEPAC ; … 16 (2015) 5, pp. 507-515
Persistent link: https://www.econbiz.de/10011299216
Cover Image
Costs and benefits of home care for the elderly versus residential care : a comparison using propensity scores
Kok, Lucy; Berden, Caroline; Sadiraj, Klarita - In: The European journal of health economics : HEPAC ; … 16 (2015) 2, pp. 119-131
Persistent link: https://www.econbiz.de/10011299560
Cover Image
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340
Persistent link: https://www.econbiz.de/10010360871
Cover Image
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom
Samyshkin, Yevgeniy; Kotchie, Robert W.; Mörk, Ann-Christin - In: The European journal of health economics : HEPAC ; … 15 (2014) 1, pp. 69-82
Persistent link: https://www.econbiz.de/10010235895
Cover Image
Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
Hidalgo Vega, Alvaro; Ramos-Goñi, Juan Manuel; … - In: The European journal of health economics : HEPAC ; … 15 (2014) 9, pp. 917-925
Persistent link: https://www.econbiz.de/10010478210
Cover Image
On the welfare theoretic foundation of CEA : comment
Breyer, Friedrich - In: The European journal of health economics : HEPAC ; … 11 (2010) 6, pp. 595-596
Persistent link: https://www.econbiz.de/10008749059
Cover Image
Does health technology assessment guidance give adequate consideration to decisions about less costly and less effective alternatives?
Griffin, Susan; Fusco, Francesco; Naidoo, Bhash; … - 2020
Persistent link: https://www.econbiz.de/10013168879